Xvivo Perfusion AB (publ) (FRA:3XV)
Germany · Delayed Price · Currency is EUR 21.92
+0.96 (4.58%)
At close: Jan 27, 2026
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of €673.35 million as of January 30, 2026. Its market cap has decreased by -48.22% in one year.
Market Cap
673.35M
Enterprise Value
657.46M
Revenue
75.05M
Ranking
n/a
PE Ratio
289.60
Stock Price
€21.92
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 43.22M to 673.35M, an increase of 1,458.08%. That is a compound annual growth rate of 22.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 673.35M | 23.86% |
| Dec 30, 2025 | 543.65M | -59.55% |
| Dec 30, 2024 | 1.34B | 44.37% |
| Dec 29, 2023 | 931.03M | 89.99% |
| Dec 30, 2022 | 490.04M | -38.91% |
| Dec 30, 2021 | 802.14M | -10.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |
| Maschinenfabrik Berthold Hermle AG | 787.50M |
| Paul Hartmann AG | 777.83M |
| EUROKAI GmbH & Co. KGaA | 688.26M |
| FRoSTA Aktiengesellschaft | 656.73M |
| Südwestdeutsche Salzwerke AG | 640.96M |